CN103361307B - The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain - Google Patents

The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain Download PDF

Info

Publication number
CN103361307B
CN103361307B CN201310254446.2A CN201310254446A CN103361307B CN 103361307 B CN103361307 B CN 103361307B CN 201310254446 A CN201310254446 A CN 201310254446A CN 103361307 B CN103361307 B CN 103361307B
Authority
CN
China
Prior art keywords
nutrient solution
c3h10t1
cell
days
induced liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310254446.2A
Other languages
Chinese (zh)
Other versions
CN103361307A (en
Inventor
宁光
张晓燕
杨颖�
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ruinjin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Co Ltd
Original Assignee
Ruinjin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruinjin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Co Ltd filed Critical Ruinjin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Co Ltd
Priority to CN201310254446.2A priority Critical patent/CN103361307B/en
Publication of CN103361307A publication Critical patent/CN103361307A/en
Application granted granted Critical
Publication of CN103361307B publication Critical patent/CN103361307B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to the method for inducing differentiation of cell, in particular to the method for inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain, its step comprises: C3H10T1/2 cell cultures cultivated in nutrient solution, cell adds 0.25% pancreatin 5mL after reaching 80%-90% fusion to be digested, trysinization reaction is stopped when cellular contraction is rounded, centrifugal 3-5 minute, precipitation, supernatant discarded, then to blow and beat after adding nutrient solution; Cultivate to 6 orifice plates or 12 orifice plates in 1:4 ratio Secondary Culture, within every 2-4 days, change nutrient solution 1 time; The cell treating on culture plate covers with and is placed in induced liquid A, removes induced liquid A and changes induced liquid B into, remove induced liquid B and change nutrient solution into after 2 days after 2 days, within every 2-4 days, changes nutrient solution 1 time.The adipocyte of the differentiation-inducing one-tenth of the present invention, can apply in follow-up experiment well.

Description

The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain
Technical field
The present invention relates to the method for inducing differentiation of cell, the method for inducing differentiation of particularly a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain.
Background technology
Along with the raising of economic level, the continuing to increase of life stress, the change of people's dietary structure, momental minimizing, the morbidity of disease of causeing fat rises rapidly, and the overweight or population of being obese in the whole world about reaches 1,000,000,000 at present according to estimates.Obesity is as one of the main ingredient of metabolism syndrome, and as closely related in diabetes B, hyperlipemia, hypertension, coronary heart disease with various diseases, the health of the serious harm mankind, affects and annoying daily life.Recent study finds, autophagy plays an important role in the lipid metabolism of liver and fatty tissue, autophagy is one and engulfs own cells matter albumen or organoid and make it wrap and entered vesica, and form autophagy lysosome with lysosome fusion, degrade the process of its content wrapped up, the metabolism realizing cell itself by this needs and the renewal of some organoid.So autophagy phenomenon is that the treatment of obesity provides new thinking.
Berberine is a kind of isoquinoline alkaloid, it is the main component of Chinese Drug Rhizomes of Coptis, studied in the past and confirmed that Berberine had a lot of pharmacological action and comprises antibacterial, antitumor, the expression of the inflammation-inhibiting factor TNF-α, IL-6 etc. especially can there is obvious anti-inflammatory effect at the individuality of obesity, nearest research finds that Berberine can be hypoglycemic, improves Insulin Resistance.
C3H10T1/2 clone is in 1973, separate from the C3H mouse embryonic cell of 14 to 17 days first, these cells show inoblast form in culturing process, functionally be similar to mescenchymal stem cell, if C3H10T1/2 induced orientation is divided into PECTORAL LIMB SKELETON, and then be divided into mature fat cell according to the induction scheme of standard, show the characteristic of fat, and then apply C3H10T1/2 mature fat cell to study the impact of Berberine on autophagy, in monitoring mature fat cell, autophagy is to the regulation and control of lipid metabolism, treatment for obesity provides new drug target and methods for the treatment of.
Summary of the invention
The object of this invention is to provide the method for inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain, pass through the method, C3H10T1/2 cell induction is divided into mature fat cell, show as the accumulation of triglyceride level and the expression of adipocyte marker protein, making C3H10T1/2 cell can apply to follow-up Berberine well suppresses in the research experiment of C3H10T1/2 adipocyte autophagy aspect, for the treatment that more reasonably Berberine can be applied to obese patient clinically provides foundation.
Object of the present invention can be achieved through the following technical solutions:
A method of inducing differentiation for C3H10T1/2 mesoderm pluripotency embryonic stem cell strain, its step comprises:
(1), cultivate and go down to posterity: by C3H10T1/2 cell cultures in nutrient solution, and being placed in 5%CO 2incubator in cultivate, reach after 80%-90% merges until cell and add 0.25% pancreatin 5mL and digest, add nutrient solution when cellular contraction is rounded and stop trysinization reaction, centrifugal 3-5 minute, precipitate, supernatant discarded, then to blow and beat after adding nutrient solution; In 1:4 ratio Secondary Culture to 6 orifice plates or 12 orifice plates, be placed in 5%CO 2incubator in cultivate, within every 2-4 days, change nutrient solution 1 time.Preferably, within every 2 days, nutrient solution 1 time is changed.
(2), differentiation-inducing: the cell treating on the culture plate in step (1) covers with and is placed in induced liquid A, remove induced liquid A after 2 days and change induced liquid B into, remove induced liquid B after 2 days and change nutrient solution into, within every 2-4 days, change nutrient solution 1 time, treat that more than 90% cell is rounded and occur that a large amount of fat drips, namely representing that C3H10T1/2 cell has been induced successfully.Preferably, within every 2 days, nutrient solution 1 time is changed.
Nutrient solution in described step (1) or step (2) is be the DMEM nutrient solution of 10%FBS containing volume percent.
In described step (1), 5%CO 2the culture temperature of incubator be 35 DEG C-40 DEG C.Preferably, 5%CO 2the culture temperature of incubator be 37 DEG C.
In described step (2), induced liquid A is be the DMEM nutrient solution of 10%FBS containing volume percent, also containing Regular Insulin 4-5 μ g/mL in this nutrient solution, 3-isobutyl-1-methylxanthine 0.5-0.7mmol/L, dexamethasone 1-2 μm ol/L, indomethacin 120-130nmol/L, triiodothyronine 1-2nmol/L, rosiglitazone 1-2 μm ol/L.Preferably, described induced liquid A is be the DMEM nutrient solution of 10%FBS containing volume percent, also containing Regular Insulin 5 μ g/mL in this nutrient solution, 3-isobutyl-1-methylxanthine 0.5mmol/L, dexamethasone 1 μm of ol/L, indomethacin 125nmol/L, triiodothyronine 1nmol/L, rosiglitazone 1 μm of ol/L.
In described step (2), induced liquid B is be the DMEM nutrient solution of 10%FBS containing volume percent, goes back insulin-containing 5-10 μ g/ml, triiodothyronine 1-3nmol/L, rosiglitazone 1-3 μm ol/L in this nutrient solution.Preferably, described induced liquid B is be the DMEM nutrient solution of 10%FBS containing volume percent, goes back insulin-containing 5 μ g/ml, triiodothyronine 1nmol/L, rosiglitazone 1 μm of ol/L in this nutrient solution.
The adipocyte of having induced in step (2) the DMEM nutrient solution containing volume percent being 0.2%BSA is hatched 10-14 hour.Preferably, the adipocyte of having induced in step (2) the DMEM nutrient solution containing volume percent being 0.2%BSA is hatched 12 hours.
The present invention has the following advantages:
1, the present invention first successfully induces the strain of C3H10T1/2 mesoderm pluripotency embryonic stem cell to be divided into adipocyte, the cells show of this maturation is the accumulation of triglyceride level and the expression of adipocyte marker protein, and C3H10T1/2 cell can be applied in follow-up experiment well.
2, the C3H10T1/2 cell that the present invention induces can be used for Berberine and suppresses in the research experiment of C3H10T1/2 adipocyte autophagy aspect, for the treatment more reasonably Berberine being used for obese patient clinically provides experimental data and theoretical foundation.
Embodiment
Below in conjunction with embodiment, the invention will be further described:
The reagent used in experiment: mesoblastic pluripotent stem cell strain C3H10T1/2 cell, purchased from American ATCC (American Type Culture Collection).Dexamethasone, 3-isobutyl-1-methylxanthine, indomethacin, triiodothyronine and rosiglitazone equal purchased from American Sigma company; Regular Insulin purchased from American Li Lai company; Bovine serum albumin (Bovine serum albumin, BSA) is purchased from German Roche company; 10%FBS/DMEM nutrient solution purchased from American Gibco BRL company.
Embodiment 1
The cultivation of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain with go down to posterity:
It is in the DMEM nutrient solution of 10%FBS that C3H10T1/2 cell routine is incubated at containing per-cent, puts 5%CO 2, 37 DEG C of incubators are hatched, reach after 80%-90% fusion until cell, in super clean bench with transfer pipet by nutrient solution sucking-off, add 0.25% pancreatin 5mL to digest, see that cellular contraction is rounded under microscope, adding containing per-cent is stop trysinization reaction in the DMEM nutrient solution of 10%FBS, cell residual on bottle wall is is repeatedly blown and beaten with transfer pipet, make cell detachment culturing bottle wall, suck and be equipped with in the centrifuge tube of nutrient solution, the centrifugal 3min of 1000rpm, sedimentation cell, after centrifugal, supernatant discarded, adding containing per-cent is the DMEM nutrient solution of 10%FBS again, blow and beat with transfer pipet, cell dispersal is opened.In 1:4 ratio Secondary Culture to 6 orifice plates or 12 orifice plates, put 5%CO 2incubator is cultivated, and culture temperature is 37 DEG C, then, within every 2 days, changes nutrient solution (being the DMEM nutrient solution of 10%FBS containing per-cent) 1 time.
Embodiment 2
C3H10T1/2 mesoderm pluripotency embryonic stem cell strain differentiation-inducing:
The cell treating on culture plate covers with and is placed on induced liquid A(and contains the DMEM nutrient solution that per-cent is 10%FBS, also containing Regular Insulin 5ug/ml in this nutrient solution, 3-isobutyl-1-methylxanthine 0.5mmol/L, dexamethasone 1 μm of ol/L, indomethacin 125nmol/L, triiodothyronine 1nmol/L, rosiglitazone 1 μm of ol/L), remove induced liquid A after 2 days to change induced liquid B(into and contain the DMEM nutrient solution that per-cent is 10%FBS, also containing Regular Insulin 5 μ g/ml in this nutrient solution, triiodothyronine 1nmol/L, rosiglitazone 1 μm of ol/L), removing after 2 days that induced liquid B changes into containing per-cent is the DMEM nutrient solution of 10%FBS, change a nutrient solution every other day later.Treat that more than 90% cell is rounded and occur that a large amount of fat drips, namely representing that C3H10T1/2 cell has been induced successfully, become ripe adipocyte.The adipocyte of the having induced DMEM containing volume percent being 0.2%BSA is hatched 12 hours, follow-up Berberine can be carried out and suppress in the research experiment of C3H10T1/2 adipocyte autophagy aspect.
The above is preferred embodiment of the present invention, but the present invention should not be confined to the content disclosed in this embodiment.The equivalence completed under not departing from spirit disclosed in this invention so every or amendment, all fall into the scope of protection of the invention.

Claims (4)

1. a method of inducing differentiation for C3H10T1/2 mesoderm pluripotency embryonic stem cell strain, its step comprises:
(1), cultivate and go down to posterity: by C3H10T1/2 cell cultures in nutrient solution, and being placed in 5%CO 2incubator in cultivate, reach after 80%-90% merges until cell and add 0.25% pancreatin 5mL and digest, add nutrient solution when cellular contraction is rounded and stop trysinization reaction, centrifugal 3-5 minute, precipitate, supernatant discarded, then to blow and beat after adding nutrient solution; In 1:4 ratio Secondary Culture to 6 orifice plates or 12 orifice plates, be placed in 5%CO 2incubator in cultivate, within every 2-4 days, change nutrient solution 1 time;
(2), differentiation-inducing: the cell treating on the culture plate in step (1) covers with and is placed in induced liquid A, remove induced liquid A after 2 days and change induced liquid B into, remove induced liquid B after 2 days and change nutrient solution into, within every 2-4 days, change nutrient solution 1 time, treat that more than 90% cell is rounded and occur that a large amount of fat drips, namely representing that C3H10T1/2 cell has been induced successfully;
Induced liquid A is be the DMEM nutrient solution of 10%FBS containing volume percent, also containing Regular Insulin 5 μ g/mL in this nutrient solution, 3-isobutyl-1-methylxanthine 0.5mmol/L, dexamethasone 1 μm of ol/L, indomethacin 125nmol/L, triiodothyronine 1nmol/L, rosiglitazone 1 μm of ol/L;
Described induced liquid B is be the DMEM nutrient solution of 10%FBS containing volume percent, insulin-containing 5 μ g/ml, triiodothyronine 1nmol/L in this nutrient solution, rosiglitazone 1 μm of ol/L.
2. the method for inducing differentiation of C3H10T1/2 mesoderm pluripotency embryonic stem cell according to claim 1 strain, is characterized in that: the nutrient solution in described step (1) or step (2) is be the DMEM nutrient solution of 10%FBS containing volume percent.
3. the method for inducing differentiation of C3H10T1/2 mesoderm pluripotency embryonic stem cell according to claim 1 strain, is characterized in that: in described step (1), 5%CO 2the culture temperature of incubator be 35 DEG C-40 DEG C.
4. the method for inducing differentiation of C3H10T1/2 mesoderm pluripotency embryonic stem cell according to claim 1 strain, is characterized in that: the C3H10T1/2 cell of having induced in step (2) the DMEM nutrient solution containing volume percent being 0.2%BSA is hatched 10-14 hour.
CN201310254446.2A 2013-06-24 2013-06-24 The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain Active CN103361307B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310254446.2A CN103361307B (en) 2013-06-24 2013-06-24 The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310254446.2A CN103361307B (en) 2013-06-24 2013-06-24 The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain

Publications (2)

Publication Number Publication Date
CN103361307A CN103361307A (en) 2013-10-23
CN103361307B true CN103361307B (en) 2015-07-29

Family

ID=49363569

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310254446.2A Active CN103361307B (en) 2013-06-24 2013-06-24 The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain

Country Status (1)

Country Link
CN (1) CN103361307B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104651298B (en) * 2013-11-21 2019-06-04 上海交通大学医学院附属第九人民医院 Inducing embryo stem cell directed differentiation is the culture medium and method of keratinocyte
CN109097324A (en) * 2018-08-30 2018-12-28 丰泽康生物医药(深圳)有限公司 A kind of cultural method for improving monocyte and being converted to multipotential cell
CN110747163B (en) * 2019-11-13 2021-06-11 暨南大学 Method for improving adipogenic differentiation of human adipose-derived mesenchymal stem cells and special culture medium thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1912110A (en) * 2005-08-09 2007-02-14 中国人民解放军军事医学科学院野战输血研究所 Method and application of induced differentiating fat originate stem cells to adipocyte
CN103040821A (en) * 2012-12-31 2013-04-17 上海市内分泌代谢病研究所 Application of berberine in pharmacy
CN103060267A (en) * 2012-12-26 2013-04-24 上海市内分泌代谢病研究所 An induced differentiation method for 3T3-L1 preadipocytes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1912110A (en) * 2005-08-09 2007-02-14 中国人民解放军军事医学科学院野战输血研究所 Method and application of induced differentiating fat originate stem cells to adipocyte
CN103060267A (en) * 2012-12-26 2013-04-24 上海市内分泌代谢病研究所 An induced differentiation method for 3T3-L1 preadipocytes
CN103040821A (en) * 2012-12-31 2013-04-17 上海市内分泌代谢病研究所 Application of berberine in pharmacy

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BMP2 具有诱导C3H10T1/2细胞成脂肪分化的能力;谢在春 等;《中国生物化学与分子生物学报》;20080228;第24卷(第2期);142-147页 *
Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage;Qi-Qun Tang 等;《PNAS》;20040629;第101卷(第26期);9607-9611页 *
多潜能C3H/10T1/2细胞增殖、分化相关新基因的捕获、克隆及功能研究;王明科;《中国博士学位论文全文数据库》;20101215(第12期);E059-11页 *

Also Published As

Publication number Publication date
CN103361307A (en) 2013-10-23

Similar Documents

Publication Publication Date Title
CN106265740B (en) Umbilical cord mesenchymal stem cells combine application of the astragalus polyose in treatment hyperglycaemia and medicine for treating diabetic nephropathy is prepared
CN106916787B (en) A kind of limbal stem cell culture medium and its cultural method
CN103361307B (en) The method of inducing differentiation of a kind of C3H10T1/2 mesoderm pluripotency embryonic stem cell strain
CN105132369B (en) A kind of derivant and inducing culture that mescenchymal stem cell is converted into testosterone secretion cell
CN105331583B (en) A method of promote people to induce multi-potent stem cell and breaks up to Neuronal induction
CN104232574A (en) Method for in-vitro directional differentiation inducing of mesenchymal stem cell towards melanocyte
Jin et al. In vitro induction and differentiation of umbilical cord mesenchymal stem cells into neuron-like cells by all-trans retinoic acid
CN107217028A (en) A kind of organization engineering skin containing appendicle and preparation method thereof
CN106350521A (en) Preparation method of ALS (Amyotrophic Lateral Sclerosis) patient specific motor neuron
Liu et al. Skin epithelial cells as possible substitutes for ameloblasts during tooth regeneration
CN104450606B (en) Sweat gland cells inducing culture and its application
Li et al. Asiatic acid inhibits adipogenic differentiation of bone marrow stromal cells
Li et al. Effect of polysaccharide of dendrobium candidum on proliferation and apoptosis of human corneal epithelial cells in high glucose
CN103356611A (en) Application of berberine in preparation of weight-loss drug
CN106282094A (en) The method that the precursor in application on human skin source is induced to differentiate into corneal endothelium like cell
CN1932010B (en) Process of separating endothelial ancestral cell from human fat tissue
CN102199081A (en) 2-acetylaloeemodin and preparation method and application thereof
Zang et al. Insulin negatively regulates dedifferentiation of mouse adipocytes in vitro
Pan et al. The injury effect of oxygen free radicals in vitro on cultured pulmonary artery endothelial cells from broilers
WO2022056991A1 (en) Mesenchymal stem cells derived from umbilical cord, and preparation method therefor and use thereof
CN104415031A (en) Application of wedelolactone in preparation of medicaments or healthcare products for treating osteoporosis
CN102229528B (en) Method for extracting unsaturated fatty acid composition from humen amniotic epithelial cells, and application thereof
CN102140436A (en) Culture solution for differentiating adipose-derived stromal cells into myocardial cells and preparation method thereof
CN106244531A (en) A kind of human amnion mesenchymal stem cell isolated culture method
CN105687209B (en) Application of the Salvia Miltiorrhiza Monomer compound in preparation enhancing iPS characteristics of cell biology product

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant